Laronidase is an enzyme replacement therapy used to treat Mucopolysaccharidosis I (MPS I). It replaces the missing natural enzyme alpha-L-iduronidase to clear harmful sugar buildups in the body. It is given weekly through an intravenous (IV) infusion.
Laronidase is an enzyme replacement therapy used to treat Mucopolysaccharidosis I (MPS I). It replaces the missing natural enzyme alpha-L-iduronidase to clear harmful sugar buildups in the body. It is given weekly through an intravenous (IV) infusion.